Since the clinical outcome for ESCC patients remains poor, and few prognostic factors currently exist for this disease following surgery, IL-6 or IL-8 might serve as clinical markers for ESCC patients in the future. The gene discussed is CXCL8; the disease is esophageal squamous cell carcinoma.